vs
Clear Channel Outdoor Holdings, Inc.（CCO）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Clear Channel Outdoor Holdings, Inc.的1.3倍（$622.0M vs $461.5M），Royalty Pharma plc净利率更高（34.4% vs 1.7%，领先32.7%），Clear Channel Outdoor Holdings, Inc.同比增速更快（8.2% vs 4.8%），过去两年Clear Channel Outdoor Holdings, Inc.的营收复合增速更高（18.8% vs 4.6%）
Clear Channel Outdoor Holdings, Inc.是一家专注于户外广告业务的跨国企业，总部位于美国得克萨斯州圣安东尼奥，在全球多个市场布局户外广告媒体网络，为各类品牌客户提供场景化的户外广告传播服务。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CCO vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.3倍
$461.5M
营收增速更快
CCO
高出3.4%
4.8%
净利率更高
RPRX
高出32.7%
1.7%
两年增速更快
CCO
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $461.5M | $622.0M |
| 净利润 | $8.0M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 23.3% | 62.4% |
| 净利率 | 1.7% | 34.4% |
| 营收同比 | 8.2% | 4.8% |
| 净利润同比 | 144.8% | 2.9% |
| 每股收益（稀释后） | $0.01 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCORPRX
| Q4 25 | $461.5M | $622.0M | ||
| Q3 25 | $405.6M | $609.3M | ||
| Q2 25 | $402.8M | $578.7M | ||
| Q1 25 | $334.2M | $568.2M | ||
| Q4 24 | $426.7M | $593.6M | ||
| Q3 24 | $375.2M | $564.7M | ||
| Q2 24 | $376.5M | $537.3M | ||
| Q1 24 | $326.8M | $568.0M |
净利润CCORPRX
| Q4 25 | $8.0M | $214.2M | ||
| Q3 25 | $-60.1M | $288.2M | ||
| Q2 25 | $9.5M | $30.2M | ||
| Q1 25 | $62.5M | $238.3M | ||
| Q4 24 | $-17.9M | $208.2M | ||
| Q3 24 | $-32.5M | $544.0M | ||
| Q2 24 | $-39.2M | $102.0M | ||
| Q1 24 | $-89.7M | $4.8M |
营业利润率CCORPRX
| Q4 25 | 23.3% | 62.4% | ||
| Q3 25 | 19.9% | 70.1% | ||
| Q2 25 | 19.2% | 36.3% | ||
| Q1 25 | 13.5% | 94.0% | ||
| Q4 24 | 23.5% | 60.9% | ||
| Q3 24 | 17.8% | — | ||
| Q2 24 | 18.2% | 50.2% | ||
| Q1 24 | 13.4% | -13.0% |
净利率CCORPRX
| Q4 25 | 1.7% | 34.4% | ||
| Q3 25 | -14.8% | 47.3% | ||
| Q2 25 | 2.4% | 5.2% | ||
| Q1 25 | 18.7% | 41.9% | ||
| Q4 24 | -4.2% | 35.1% | ||
| Q3 24 | -8.7% | 96.3% | ||
| Q2 24 | -10.4% | 19.0% | ||
| Q1 24 | -27.4% | 0.8% |
每股收益（稀释后）CCORPRX
| Q4 25 | $0.01 | $0.49 | ||
| Q3 25 | $-0.12 | $0.67 | ||
| Q2 25 | $0.02 | $0.07 | ||
| Q1 25 | $0.13 | $0.55 | ||
| Q4 24 | $-0.03 | $0.46 | ||
| Q3 24 | $-0.07 | $1.21 | ||
| Q2 24 | $-0.08 | $0.23 | ||
| Q1 24 | $-0.19 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $190.0M | $618.7M |
| 总债务越低越好 | $5.1B | $9.0B |
| 股东权益账面价值 | $-3.4B | $9.7B |
| 总资产 | $3.8B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CCORPRX
| Q4 25 | $190.0M | $618.7M | ||
| Q3 25 | $155.0M | $938.9M | ||
| Q2 25 | $138.6M | $631.9M | ||
| Q1 25 | $395.8M | $1.1B | ||
| Q4 24 | $109.7M | $929.0M | ||
| Q3 24 | $201.1M | $950.1M | ||
| Q2 24 | $189.3M | $1.8B | ||
| Q1 24 | $193.2M | $843.0M |
总债务CCORPRX
| Q4 25 | $5.1B | $9.0B | ||
| Q3 25 | $5.1B | $8.9B | ||
| Q2 25 | $5.1B | $8.0B | ||
| Q1 25 | $5.3B | $7.6B | ||
| Q4 24 | $5.7B | $7.6B | ||
| Q3 24 | $5.7B | $7.6B | ||
| Q2 24 | $5.7B | $7.6B | ||
| Q1 24 | $5.7B | $6.1B |
股东权益CCORPRX
| Q4 25 | $-3.4B | $9.7B | ||
| Q3 25 | $-3.5B | $9.6B | ||
| Q2 25 | $-3.4B | $9.5B | ||
| Q1 25 | $-3.4B | $9.8B | ||
| Q4 24 | $-3.6B | $10.3B | ||
| Q3 24 | $-3.6B | $10.3B | ||
| Q2 24 | $-3.6B | $9.8B | ||
| Q1 24 | $-3.5B | $9.9B |
总资产CCORPRX
| Q4 25 | $3.8B | $19.6B | ||
| Q3 25 | $3.8B | $19.3B | ||
| Q2 25 | $3.8B | $18.3B | ||
| Q1 25 | $4.0B | $17.6B | ||
| Q4 24 | $4.8B | $18.2B | ||
| Q3 24 | $4.6B | $18.0B | ||
| Q2 24 | $4.5B | $17.7B | ||
| Q1 24 | $4.6B | $16.1B |
负债/权益比CCORPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $56.3M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $30.3M | — |
| 自由现金流率自由现金流/营收 | 6.6% | — |
| 资本支出强度资本支出/营收 | 5.6% | — |
| 现金转化率经营现金流/净利润 | 7.04× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $32.0M | — |
8季度趋势，按日历期对齐
经营现金流CCORPRX
| Q4 25 | $56.3M | $827.1M | ||
| Q3 25 | $56.2M | $702.6M | ||
| Q2 25 | $-12.6M | $364.0M | ||
| Q1 25 | $14.9M | $596.1M | ||
| Q4 24 | $29.3M | $742.5M | ||
| Q3 24 | $54.5M | $703.6M | ||
| Q2 24 | $30.8M | $658.2M | ||
| Q1 24 | $-34.8M | $664.6M |
自由现金流CCORPRX
| Q4 25 | $30.3M | — | ||
| Q3 25 | $41.4M | — | ||
| Q2 25 | $-29.2M | — | ||
| Q1 25 | $-10.6M | — | ||
| Q4 24 | $-27.8M | — | ||
| Q3 24 | $21.0M | — | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $-61.0M | — |
自由现金流率CCORPRX
| Q4 25 | 6.6% | — | ||
| Q3 25 | 10.2% | — | ||
| Q2 25 | -7.2% | — | ||
| Q1 25 | -3.2% | — | ||
| Q4 24 | -6.5% | — | ||
| Q3 24 | 5.6% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | -18.7% | — |
资本支出强度CCORPRX
| Q4 25 | 5.6% | — | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | 4.1% | — | ||
| Q1 25 | 7.6% | — | ||
| Q4 24 | 13.4% | — | ||
| Q3 24 | 8.9% | — | ||
| Q2 24 | 6.8% | — | ||
| Q1 24 | 8.0% | — |
现金转化率CCORPRX
| Q4 25 | 7.04× | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | -1.32× | 12.06× | ||
| Q1 25 | 0.24× | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCO
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
